<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e>, associated with fibroblast growth factor receptor (FGFR) 2 mutations, is characterized by premature fusion of cranial sutures </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed proliferation and differentiation of calvaria cells derived from <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> infants and fetuses with FGFR-2 mutations </plain></SENT>
<SENT sid="2" pm="."><plain>Histological analysis revealed premature ossification, increased extent of subperiosteal bone formation, and alkaline phosphatase- positive preosteoblastic cells in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> fetal calvaria compared with age-matched controls </plain></SENT>
<SENT sid="3" pm="."><plain>Preosteoblastic calvaria cells isolated from <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> infants and fetuses showed <z:mpath ids='MPATH_458'>normal</z:mpath> cell growth in basal conditions or in response to exogenous FGF-2 </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the number of alkaline phosphatase- positive calvaria cells was fourfold higher than <z:mpath ids='MPATH_458'>normal</z:mpath> in mutant fetal calvaria cells with the most frequent <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> FGFR-2 mutation (Ser252Trp), suggesting increased maturation rate of cells in the osteoblastic lineage </plain></SENT>
<SENT sid="5" pm="."><plain>Biochemical and Northern blot analyses also showed that the expression of alkaline phosphatase and type 1 collagen were 2-10-fold greater than <z:mpath ids='MPATH_458'>normal</z:mpath> in mutant fetal calvaria cells </plain></SENT>
<SENT sid="6" pm="."><plain>The in vitro production of mineralized matrix formed by immortalized mutant fetal calvaria cells cultured in aggregates was also increased markedly compared with control immortalized fetal calvaria cells </plain></SENT>
<SENT sid="7" pm="."><plain>The results show that <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> FGFR-2 mutations lead to an increase in the number of precursor cells that enter the osteogenic pathway, leading ultimately to increased subperiosteal bone matrix formation and premature calvaria ossification during fetal development, which establishes a connection between the altered genotype and <z:mp ids='MP_0005384'>cellular phenotype</z:mp> in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> syndromic <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> </plain></SENT>
</text></document>